300147 香雪制药
已收盘 07-26 15:00:00
资讯
新帖
简况
香雪制药(300147)7月24日主力资金净卖出94.33万元
证券之星 · 07-25 09:20
香雪制药(300147)7月24日主力资金净卖出94.33万元
整合资源 香雪制药(300147.SZ)拟出让北京香雪51%股权
智通财经 · 07-19
整合资源 香雪制药(300147.SZ)拟出让北京香雪51%股权
香雪制药(300147)7月16日主力资金净卖出16.81万元
证券之星 · 07-17
香雪制药(300147)7月16日主力资金净卖出16.81万元
【企业动态】香雪制药新增1件法院诉讼,案由为金融借款合同纠纷
证券之星 · 07-17
【企业动态】香雪制药新增1件法院诉讼,案由为金融借款合同纠纷
香雪制药:公司在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术
每日经济新闻 · 07-15
香雪制药:公司在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术
香雪制药(300147)7月5日主力资金净买入873.40万元
证券之星 · 07-08
香雪制药(300147)7月5日主力资金净买入873.40万元
A股收评:深成指、创业板指翻红,成交额继续低于6000亿元,医药股大反弹
格隆汇 · 07-05
A股收评:深成指、创业板指翻红,成交额继续低于6000亿元,医药股大反弹
国家药监局最新部署!加强中药标准管理工作,概念股闻风而动
格隆汇 · 07-05
国家药监局最新部署!加强中药标准管理工作,概念股闻风而动
香雪制药:公司会持续加强与投资者的沟通交流,保持与投资者的交流渠道畅通
证券之星 · 06-28
香雪制药:公司会持续加强与投资者的沟通交流,保持与投资者的交流渠道畅通
香雪制药:在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术
每日经济新闻 · 06-28
香雪制药:在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术
香雪制药与九州通召开2024年业务沟通会
证券时报网 · 06-26
香雪制药与九州通召开2024年业务沟通会
共拓新局!香雪制药携手九州通集团推动2024年业务发展新篇章
香雪制药 · 06-26
共拓新局!香雪制药携手九州通集团推动2024年业务发展新篇章
香雪制药(300147.SZ)拟作价8804万元转让德庆县南药产业园项目资产 化解相关债务纠纷
智通财经 · 06-21
香雪制药(300147.SZ)拟作价8804万元转让德庆县南药产业园项目资产 化解相关债务纠纷
香雪制药最新公告:子公司香雪南药将德庆县南药产业园项目资产转让给德庆县兴顺农业发展有限公司
证券之星 · 06-21
香雪制药最新公告:子公司香雪南药将德庆县南药产业园项目资产转让给德庆县兴顺农业发展有限公司
香雪制药:公司在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术
每日经济新闻 · 06-14
香雪制药:公司在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术
香雪制药:感谢对公司的关注与建议。我们会及时把您的意见向公司相关部门反馈
证券之星 · 06-13
香雪制药:感谢对公司的关注与建议。我们会及时把您的意见向公司相关部门反馈
香雪制药:公司2023年年度报告请查看巨潮网2024年4月30日的相关公告
证券之星 · 05-11
香雪制药:公司2023年年度报告请查看巨潮网2024年4月30日的相关公告
香雪制药(300147)5月9日主力资金净卖出4786.67万元
证券之星 · 05-10
香雪制药(300147)5月9日主力资金净卖出4786.67万元
香雪制药(300147)5月8日主力资金净买入9714.70万元
证券之星 · 05-09
香雪制药(300147)5月8日主力资金净买入9714.70万元
香雪制药:目前公司未触及《深圳证券交易所创业板股票上市规则》(2023年8月修订)相关风险警示指标
证券之星 · 05-08
香雪制药:目前公司未触及《深圳证券交易所创业板股票上市规则》(2023年8月修订)相关风险警示指标
公司概况
公司名称:
广州市香雪制药股份有限公司
所属行业:
医药制造业
上市日期:
2010-12-15
主营业务:
广州市香雪制药股份有限公司的主营业务为现代中药及中药饮片的研发、生产与销售,辅之医疗器械、少量西药产品及医药流通等业务。公司主要产品有医药产品、医疗器械、医药流通、软饮料、防疫用品、T细胞免疫治疗等。香雪制药为广东省著名品牌,香雪商标相继被评为“广州市著名商标”、“广东省著名商标”、“中国驰名商标”。公司主导产品抗病毒口服液是公司原创的新药,是全国率先应用“中药指纹图谱技术”进行质量控制的纯天然中药配方的口服制剂,公司就该类药品第一个获得新药证书、第一个获得卫生部中成药保护证书,并接连在“全国健康行业最具影响力品牌评选”中被评为“最具影响力感冒发热类药”,公司参与编制的抗病毒口服液国家标准作为生产该类产品企业的行业规范已收载于《中国药典》;香雪化橘红中药饮片产品符合广东省优质中药饮片评定标准,被评为首批广东省优质中药饮片。
发行价格:
33.99
{"stockData":{"symbol":"300147","market":"SZ","secType":"STK","nameCN":"香雪制药","latestPrice":3.29,"timestamp":1721977404000,"preClose":3.25,"halted":0,"volume":6450349,"delay":0,"floatShares":657000000,"shares":661000000,"eps":-0.649,"marketStatus":"已收盘","marketStatusCode":5,"change":0.04,"latestTime":"07-26 15:00:00","open":3.26,"high":3.32,"low":3.25,"amount":21232900,"amplitude":0.0215,"askPrice":3.3,"askSize":1908,"bidPrice":3.29,"bidSize":1054,"shortable":0,"etf":0,"ttmEps":-0.649,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722216600000},"adr":0,"adjPreClose":3.25,"symbolType":"stock","openAndCloseTimeList":[[1721957400000,1721964600000],[1721970000000,1721977200000]],"highLimit":3.58,"lowLimit":2.93,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":661279045,"pbRate":1.14,"roa":"--","roe":"--","epsLYR":-0.59,"committee":-0.355411,"marketValue":2176000000,"floatMarketCap":2163000000,"peRate":-5.069338,"changeRate":0.0123,"turnoverRate":0.0098,"status":0},"requestUrl":"/m/hq/s/300147/wiki","defaultTab":"wiki","newsList":[{"id":"2454861065","title":"香雪制药(300147)7月24日主力资金净卖出94.33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454861065","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454861065?lang=zh_cn&edition=full","pubTime":"2024-07-25 09:20","pubTimestamp":1721870420,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月24日收盘,香雪制药报收于3.29元,下跌4.64%,换手率1.96%,成交量12.92万手,成交额4352.67万元。近5日资金流向一览见下表:香雪制药融资融券信息显示,融资方面,当日融资买入89.5万元,融资偿还235.52万元,融资净偿还146.02万元。香雪制药主营业务:现代中药及中药饮片的研发、生产与销售,辅之医疗器械、软饮料、少量西药产品及医药流通等业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500014731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300147","BK0239","BK0028","BK0060","BK0070"],"gpt_icon":0},{"id":"2452429185","title":"整合资源 香雪制药(300147.SZ)拟出让北京香雪51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2452429185","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452429185?lang=zh_cn&edition=full","pubTime":"2024-07-19 18:58","pubTimestamp":1721386691,"startTime":"0","endTime":"0","summary":"智通财经APP讯,香雪制药(300147.SZ)公告,公司与北京六桂堂企业管理科技有限公司(简称“北京六桂堂”)签署了《股权转让协议》,以2386.8万元的价格向其转让公司持有的控股子公司北京香雪医药生物科技有限公司(简称“北京香雪”)51%股权。据悉,该事项有利于进一步整合资源、补充公司流动资金,提升整体运营水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300147","BK0060","BK0070","BK0239","BK0028"],"gpt_icon":0},{"id":"2452975116","title":"香雪制药(300147)7月16日主力资金净卖出16.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452975116","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452975116?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:19","pubTimestamp":1721179178,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月16日收盘,香雪制药报收于3.39元,下跌2.31%,换手率1.77%,成交量11.64万手,成交额3950.27万元。近5日资金流向一览见下表:香雪制药融资融券信息显示,融资方面,当日融资买入195.75万元,融资偿还331.48万元,融资净偿还135.73万元。香雪制药主营业务:现代中药及中药饮片的研发、生产与销售,辅之医疗器械、软饮料、少量西药产品及医药流通等业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700015225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300147","BK0239","BK0028","BK0060","BK0070"],"gpt_icon":0},{"id":"2452925796","title":"【企业动态】香雪制药新增1件法院诉讼,案由为金融借款合同纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2452925796","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452925796?lang=zh_cn&edition=full","pubTime":"2024-07-17 05:46","pubTimestamp":1721166367,"startTime":"0","endTime":"0","summary":"本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700011199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0070","159940","300147","BK0028","BK0239"],"gpt_icon":0},{"id":"2451061648","title":"香雪制药:公司在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2451061648","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451061648?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:48","pubTimestamp":1721033328,"startTime":"0","endTime":"0","summary":"在此建议董事会力邀实力人士入股贵司,特别是合生展集团,朱氏兄弟中的朱孟依入股,将为公司发带来强大的经济后盾,为创新药研发谱写传奇香雪香雪制药7月15日在投资者互动平台表示,公司在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术,主要产品包括TAEST16001、TAEST1901等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071516491795bf5b35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071516491795bf5b35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0060","159938","300147","688221","BK0070","BK0028"],"gpt_icon":0},{"id":"2449572797","title":"香雪制药(300147)7月5日主力资金净买入873.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449572797","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449572797?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:10","pubTimestamp":1720401043,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月5日收盘,香雪制药报收于3.68元,上涨14.64%,换手率7.46%,成交量49.01万手,成交额1.79亿元。近5日资金流向一览见下表:香雪制药融资融券信息显示,融资方面,当日融资买入717.43万元,融资偿还983.77万元,融资净偿还266.33万元。香雪制药主营业务:现代中药及中药饮片的研发、生产与销售,辅之医疗器械、软饮料、少量西药产品及医药流通等业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800001806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0070","BK0239","BK0060","300147"],"gpt_icon":0},{"id":"2449623234","title":"A股收评:深成指、创业板指翻红,成交额继续低于6000亿元,医药股大反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=2449623234","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449623234?lang=zh_cn&edition=full","pubTime":"2024-07-05 15:14","pubTimestamp":1720163667,"startTime":"0","endTime":"0","summary":"沪指跌0.26%报2949点,深证成指跌涨0.25%,创业板指涨0.51%。","market":"sg","thumbnail":"https://img3.gelonghui.com/a48cd-6da2875c-c1af-4256-a34f-0987cf96fa90.png","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a48cd-6da2875c-c1af-4256-a34f-0987cf96fa90.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/833064","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["300147","300391","BK0164","BK0082","BK0028","BK0070","BK0012","BK0183","BK0188","BK1574","BK0216","BK0081","BK0010","BK0224","301333","BK0006","BK0239","BK0242","BK1515","BK0086","09939","600489","BK0127","BK1161","BK0071","BK0264","600733","BK0060","BK0077"],"gpt_icon":0},{"id":"2449286037","title":"国家药监局最新部署!加强中药标准管理工作,概念股闻风而动","url":"https://stock-news.laohu8.com/highlight/detail?id=2449286037","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449286037?lang=zh_cn&edition=full","pubTime":"2024-07-05 11:00","pubTimestamp":1720148454,"startTime":"0","endTime":"0","summary":"中药材淡季“不淡”","market":"sg","thumbnail":"https://img3.gelonghui.com/47414-e2ee796d-fa30-431e-850b-4dd709a4b56e.jpg?guru_height=959&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/47414-e2ee796d-fa30-431e-850b-4dd709a4b56e.jpg?guru_height=959&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/831577","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0175","300147","BK0097","BK0224","BK0012","BK0028","BK0056","BK0146","BK0096","BK0070","301111","300391","BK0183","BK0077","BK0086","BK0239","BK0060","BK0188","600518","BK0196","BK0187","BK0132","300534"],"gpt_icon":0},{"id":"2446573770","title":"香雪制药:公司会持续加强与投资者的沟通交流,保持与投资者的交流渠道畅通","url":"https://stock-news.laohu8.com/highlight/detail?id=2446573770","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446573770?lang=zh_cn&edition=full","pubTime":"2024-06-28 17:00","pubTimestamp":1719565258,"startTime":"0","endTime":"0","summary":"证券之星消息,香雪制药06月28日在投资者关系平台上答复投资者关心的问题。建议公司积极开展研究,提升估值啊香雪制药董秘:您好,感谢对公司的关注与建议。公司会持续加强与投资者的沟通交流,保持与投资者的交流渠道畅通。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800036527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300147","BK0060","BK0028"],"gpt_icon":0},{"id":"2446522315","title":"香雪制药:在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2446522315","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446522315?lang=zh_cn&edition=full","pubTime":"2024-06-28 15:32","pubTimestamp":1719559965,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:除了抗病毒口服液这些产品,公司在生物医药领域有什么前沿布局。建议公司积极开展研究,提升估值啊香雪制药(300147.SZ)6月28日在投资者互动平台表示,公司在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术,主要产品包括TAEST16001、TAEST1901等。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406281532589f6f5af4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406281532589f6f5af4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","BK0070","BK0239","688221","300147","BK0028","BK0060"],"gpt_icon":0},{"id":"2446159351","title":"香雪制药与九州通召开2024年业务沟通会","url":"https://stock-news.laohu8.com/highlight/detail?id=2446159351","media":"证券时报网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446159351?lang=zh_cn&edition=full","pubTime":"2024-06-26 16:55","pubTimestamp":1719392100,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,据香雪制药消息,6月24日,香雪制药运营系统总经理谭光华一行莅临九州通集团,双方在集团总部召开2024年业务沟通会。此次会议以开拓和发展为核心,旨在加强双方业务沟通交流,并以此为契机启动九州通与香雪制药的全国业务合作,共同开拓更广阔的发展空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062616564595d9af8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062616564595d9af8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0146","BK0239","300147","600998","BK0183","BK0187","BK0201","BK0196","BK0250","BK0188","BK0039","BK0028","BK0097","BK0060","BK0012","BK0077"],"gpt_icon":0},{"id":"2446351152","title":"共拓新局!香雪制药携手九州通集团推动2024年业务发展新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=2446351152","media":"香雪制药","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446351152?lang=zh_cn&edition=full","pubTime":"2024-06-26 16:49","pubTimestamp":1719391786,"startTime":"0","endTime":"0","summary":"6月24日, 香雪制药 运营系统总经理谭光华先生一行莅临 九州通 集团,双方在集团总部召开2024年业务沟通会。本次会议以开拓和发展为核心,旨在加强双方业务沟通交流,并以此为契机启动九州通与香雪制药的全国业务合作,共同开拓更广阔的发展空间。他期待双方能够以此次对接会为契机,进一步深化合作,敢于创新,勇于突破,共同提升香雪制药在九州通业务中的占比,开创更加美好的未来。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406261659379f672fba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406261659379f672fba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0187","BK0201","BK0039","BK0183","BK0196","300147","BK0097","BK0188","BK0012","BK0028","BK0060","BK0239","BK0070","BK0146","BK0250","600998"],"gpt_icon":0},{"id":"2445734806","title":"香雪制药(300147.SZ)拟作价8804万元转让德庆县南药产业园项目资产 化解相关债务纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2445734806","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445734806?lang=zh_cn&edition=full","pubTime":"2024-06-21 17:51","pubTimestamp":1718963470,"startTime":"0","endTime":"0","summary":"据悉,标的资产于德庆县粤港澳大湾区南药健康产业基地国道G234东侧,主要资产包括工业用地294.14亩及该地上的建筑物三幢。公司根据实际经营需要转让德庆县南药产业园项目资产,有利于进一步盘活资产、提高资产流动性及使用效率,化解由该项资产引发的相关债务纠纷,是公司严格执行整体债务风险化解方案的有力举措。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1138672.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK0060","300147","BK0239","BK0028"],"gpt_icon":0},{"id":"2445734974","title":"香雪制药最新公告:子公司香雪南药将德庆县南药产业园项目资产转让给德庆县兴顺农业发展有限公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2445734974","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445734974?lang=zh_cn&edition=full","pubTime":"2024-06-21 17:50","pubTimestamp":1718963445,"startTime":"0","endTime":"0","summary":"香雪制药公告,子公司香雪南药将德庆县南药产业园项目资产转让给德庆县兴顺农业发展有限公司,转让价格为8804万元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100039584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0060","BK0028","300147"],"gpt_icon":0},{"id":"2443612653","title":"香雪制药:公司在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2443612653","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443612653?lang=zh_cn&edition=full","pubTime":"2024-06-14 15:17","pubTimestamp":1718349460,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:世界首例自体再生胰岛移植成功,25年糖尿病患者被治愈的新闻被刷屏,公司是否储备有此类技术,进展如何?香雪制药(300147.SZ)6月13日在投资者互动平台表示,公司无以上技术储备。公司在前沿生物技术医药研发领域的主要研究方向为T细胞免疫治疗技术,主要产品包括TAEST16001、TAEST1901等。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061415182395af8673&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061415182395af8673&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","BK0028","BK0070","BK0239","688221","300147","BK0060"],"gpt_icon":0},{"id":"2443509221","title":"香雪制药:感谢对公司的关注与建议。我们会及时把您的意见向公司相关部门反馈","url":"https://stock-news.laohu8.com/highlight/detail?id=2443509221","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443509221?lang=zh_cn&edition=full","pubTime":"2024-06-13 19:00","pubTimestamp":1718276457,"startTime":"0","endTime":"0","summary":"我们会及时把您的意见向公司相关部门反馈。希望公司的产品进展顺利,早日上市造福大众香雪制药董秘:您好,感谢对公司的关注。TAEST16001的II期临床试验阶段性总结数据于当地时间2024年6月1日以学术海报的形式在ASCO进行首次公开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061300034965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0060","300147","BK0239","BK0028"],"gpt_icon":0},{"id":"2434847463","title":"香雪制药:公司2023年年度报告请查看巨潮网2024年4月30日的相关公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2434847463","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434847463?lang=zh_cn&edition=full","pubTime":"2024-05-11 16:00","pubTimestamp":1715414433,"startTime":"0","endTime":"0","summary":"证券之星消息,香雪制药05月11日在投资者关系平台上答复投资者关心的问题。已向公司相关部门反馈。公司2023年年度报告请查看巨潮网2024年4月30日的相关公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051100017709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300147","BK0060","BK0070","BK0239","BK0028"],"gpt_icon":0},{"id":"2434075773","title":"香雪制药(300147)5月9日主力资金净卖出4786.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434075773","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434075773?lang=zh_cn&edition=full","pubTime":"2024-05-10 09:12","pubTimestamp":1715303554,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月9日收盘,香雪制药报收于4.92元,上涨6.26%,换手率19.19%,成交量126.16万手,成交额6.13亿元。近5日资金流向一览见下表:香雪制药融资融券信息显示,融资方面,当日融资买入4117.4万元,融资偿还2996.01万元,融资净买入1121.39万元。香雪制药主营业务:现代中药及中药饮片的研发、生产与销售,辅之医疗器械、软饮料、少量西药产品及医药流通等业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051000015474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300147","BK0239","BK0028","BK0060","BK0070"],"gpt_icon":0},{"id":"2434335084","title":"香雪制药(300147)5月8日主力资金净买入9714.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434335084","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434335084?lang=zh_cn&edition=full","pubTime":"2024-05-09 09:10","pubTimestamp":1715217042,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月8日收盘,香雪制药报收于4.63元,上涨19.95%,涨停,换手率13.18%,成交量86.62万手,成交额3.85亿元。近5日资金流向一览见下表:香雪制药融资融券信息显示,融资方面,当日融资买入2277.88万元,融资偿还1527.06万元,融资净买入750.82万元。香雪制药主营业务:现代中药及中药饮片的研发、生产与销售,辅之医疗器械、软饮料、少量西药产品及医药流通等业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900015051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0060","BK0028","300147"],"gpt_icon":0},{"id":"2433411707","title":"香雪制药:目前公司未触及《深圳证券交易所创业板股票上市规则》(2023年8月修订)相关风险警示指标","url":"https://stock-news.laohu8.com/highlight/detail?id=2433411707","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433411707?lang=zh_cn&edition=full","pubTime":"2024-05-08 19:00","pubTimestamp":1715166056,"startTime":"0","endTime":"0","summary":"目前公司未触及《深圳证券交易所创业板股票上市规则》相关风险警示指标。目前公司暂未单独披露ESG报告,但在年报及半年报中披露了环境保护、社会责任、公司治理等有关信息。关于公司2019年限制性股票激励计划第三期回购事项,公司会按照《2019年限制性股票激励计划》的相关规定进行回购注销,也会按照信息披露规则对相关事项进行公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800033995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399001","000001.SH","300147","399006","BK0028","BK0239","BK0070","399300","159915","159982","BK0060"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-12-15","address":"广东省广州市黄埔区广州经济技术开发区科学城金峰园路2号(自编第一、二、三、四、五、六、七、八栋)","stockEarnings":[{"period":"1week","weight":-0.0525},{"period":"1month","weight":0.0188},{"period":"3month","weight":-0.0997},{"period":"6month","weight":-0.3085},{"period":"1year","weight":-0.3845},{"period":"ytd","weight":-0.3689}],"companyName":"广州市香雪制药股份有限公司","boardCode":"AI0027","perCapita":"12800股","boardName":"医药制造业","registeredCapital":"66127万元","compareEarnings":[{"period":"1week","weight":-0.0304},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.0654},{"period":"6month","weight":-0.0081},{"period":"1year","weight":-0.1043},{"period":"ytd","weight":-0.0296}],"survey":" 广州市香雪制药股份有限公司的主营业务为现代中药及中药饮片的研发、生产与销售,辅之医疗器械、少量西药产品及医药流通等业务。公司主要产品有医药产品、医疗器械、医药流通、软饮料、防疫用品、T细胞免疫治疗等。香雪制药为广东省著名品牌,香雪商标相继被评为“广州市著名商标”、“广东省著名商标”、“中国驰名商标”。公司主导产品抗病毒口服液是公司原创的新药,是全国率先应用“中药指纹图谱技术”进行质量控制的纯天然中药配方的口服制剂,公司就该类药品第一个获得新药证书、第一个获得卫生部中成药保护证书,并接连在“全国健康行业最具影响力品牌评选”中被评为“最具影响力感冒发热类药”,公司参与编制的抗病毒口服液国家标准作为生产该类产品企业的行业规范已收载于《中国药典》;香雪化橘红中药饮片产品符合广东省优质中药饮片评定标准,被评为首批广东省优质中药饮片。","serverTime":1721996208338,"listedPrice":33.99,"stockholders":"51355人(较上一季度增加3.45%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"香雪制药(300147)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供香雪制药(300147)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"香雪制药,300147,香雪制药股票,香雪制药股票老虎,香雪制药股票老虎国际,香雪制药行情,香雪制药股票行情,香雪制药股价,香雪制药股市,香雪制药股票价格,香雪制药股票交易,香雪制药股票购买,香雪制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"香雪制药(300147)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供香雪制药(300147)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}